Sun Pharma to acquire Nasdaq-listed oncology firm Checkpoint Therapeutics for $335 million 

Checkpoint stockholders will also receive a contingent value right for up to $0.70 per share on achievement of certain milestone

Mar 10, 2025 - 09:50
 0  12
Sun Pharma to acquire Nasdaq-listed oncology firm Checkpoint Therapeutics for $335 million 
Checkpoint stockholders will also receive a contingent value right for up to $0.70 per share on achievement of certain milestone

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow